Posts Tagged ‘epclusa cost’

The reduction in the price of production of biosimilar drugs with respect to reference items has led to their replacement by biosimilar drugs in patients initiating biological therapy, adalimumab but some centers are also switching to adalimumab biosimilar in patients who are controlled with original adalimumab (Humira). The court battles are playing out as Alvotech…

Extended-term security, efficacy, and immunogenicity of adalimumab biosimilar BI 695501 and adalimumab reference product in sufferers with moderately-to-severely active rheumatoid arthritis: benefits from a phase 3b extension study (VOLTAIRE-RAext). A biosimilar is a biological solution that carries no clinical distinction from the already-approved medication but consists of comparable elements.10 The thought behind building interchangeable biosimilars…